Based on 784 businesses audited.
NEUPOGEN has 11.7 points more reputation than the average for Medical Devices, Pharma & Biotech.
Medical Devices, Pharma & Biotech Reputation: NEUPOGEN (neupogen.com)
The site is a highly compliant but technically dated pharmaceutical portal. While it avoids the typical ‘disruptive’ fluff of startups, it creates BS through clinical vagueness (‘natural defenses’) and a total lack of modern technical trust signals like structured data schema. It is more a regulatory brochure than a proof-driven clinical resource.
Medical Devices, Pharma & Biotech Reputation: NEUPOGEN (neupogen.com)
The website perfectly aligns with the Pharma & Biotech industry, characterized by dense regulatory disclosures and technical clinical terminology. The content focuses entirely on filgrastim, a G-CSF biological product, used in chemotherapy contexts.
“The score of 71 is primarily driven by technical identity gaps (8 points in Identity and Authority) and a trust theatre penalty (9 points) resulting from the lack of external proof paths and anomalous review counts. Information Density (9 points) reflects the high repetition of the value prop and the use of soft marketing language in headings despite the high-substance ISI body text.”